Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 1× · first seen 09-sep-2026 · last seen 09-sep-2026

AMC6156

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-08-03 — A Study of AMC6156 in People With Sarcopenia: Registered 12-week randomized placebo-controlled trial in older adults with sarcopenia testing daily AMC6156 for safety plus physical function and strength endpoints; protocol/aims only, no efficacy readout yet. [human-rct] (novelty: 3)

Open questions

Related

Contributing findings

clinicaltrials trial early human-rct
A Study of AMC6156 in People With Sarcopenia
03-aug-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18